1 / 15

INTRACRANIAL PRESSURE

INTRACRANIAL PRESSURE. JULY 2004. CEREBRAL BLOOD FLOW. CBF affects cerebral volume, oxygen consumption and removal of waste products. Brain receives 15-20 % of cardiac output. Grey > than white matter.

Download Presentation

INTRACRANIAL PRESSURE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. INTRACRANIAL PRESSURE JULY 2004

  2. CEREBRAL BLOOD FLOW • CBF affects cerebral volume, oxygen consumption and removal of waste products. • Brain receives 15-20 % of cardiac output. Grey > than white matter. • Receives blood via carotid arteries (80%) and vertebrobasilar arteries (20%). Form Circle of Willis • Venous blood travels in cerebral veins in arachnoid mater before draining into dural venous sinuses.

  3. AUTOREGULATION • In the healthy brain CBF remains constant despite changes in arterial pressure ie. constant between MAPs of 50-150mmHg • In chronic hypertension this is shitfted to the right.

  4. REGULATION OF CBF • CBF increases with metabolism (highest CBF occurs during seizures) • Carbon dioxide- potent vasodiltator. Increasing PaCO2 by 1kPa increases CBF by 30%. At PaCO2 >10 or <4kPa these changes are less marked • In normal range oxygen has little effect on CBF but once PaO2 is <7kPa it causes vasodilatation • Temperature. Hypothermia reduces CBF • Blood viscosity • Anaestheticagents • Neurogenic control – cerebral vessels have supply from parasympathetic and sympathetic nerves

  5. BLOOD BRAIN BARRIER • Semi-permeable capillary membrane • Regulates the movement of all solutes and hence water into CNS extracellular space and so governs cerebral volume • With trauma or inflammation the BBB becomes incompetent and places brain at risk of swelling

  6. CEREBROSPINAL FLUID • Clear aqueous fluid bathing CNS providing support and protection from trauma • Produced at rate of 500-600ml a day • Turnover time 4-5 hours so total volume is 140ml • Formed in choroid plexus in the lateral ventricles and flows into subarachnoid space around brain and spinal cord • 80-90% is absorbed at cranial site through arachnoid villi. Rest absorbed at spinal sites.

  7. INTRACRANIAL PRESSURE • Determined by the relationship between rigid cranium and volume of intacranial contents • Intracranial contents – • Brain tissue 85% • CSF 10% • Blood 5% • Pathological circumstances can produce 4th compartment –the mass lesion

  8. INTRACRANIAL HYPERTENSION • Defined as sustained ICP >15 mmHg • Blood and CSF communicate with extracranial compartments and allow a degree of adaptability • Three compensatory mechanisms- • Translocation of intracranial CSF through foramen magnum to subarachnoid space around spinal cord • Increased CSF absorption by arachnoid villi • Translocation of blood out of cranium • Once these methods are exhausted there is an abrupt rise in ICP with small increase in cerebral volume • Cerebral compliance and capacitance

  9. CAUSES OF RAISED ICP • Increased brain bulk- space occupying lesion, cerebral oedema • Increased CSF volume – benign intracranial hypertension, hydrocephalus • Increased cerebral blood flow • Increased arterial blood - hypoxia, hypercarbia, halogenated inhalational agents • Increased venous blood –coughing, straining, increased intrathoracic or intra-abdominal pressure,obstruction to venous drainage in neck, head down position

  10. CEREBRAL PERFUSION PRESSURE • CPP = MAP – ICP • IF CPP is <70mmHg, it is associated with loss of cerebral autoregulation and may increase secondary insults to the brain • In management of patient with a head injury the strategy is to maintain CPP > 70 mmHg

  11. CEREBRAL OEDEMA • Cerebral oedema commonly accompanies neuropathological processes. It is defined as an increase in water content of brain • 3 forms • Vasogenic –failure of capillary permeability when BBB is disrupted • Cytotoxic –failure of NaK pump in brain cells due to ischaemia leads to accumulation of Na and water in these cells • Interstitial –in hydrocephalus the pressure in ventricles may cause CSF to leak into ECF • In clinical practice it is usually due to vasogenic and cytotoxic processes

  12. CONING • Unrelenting cerebral swelling and increased ICP will ultimately lead to brain displacement • Herniation typically takes place in following sites • Cingulate – one hemisphere is pushed under falx cerebri compressing the ant. cerebral artery • Temporal – the medial temporal lobe is pushed through the tentorium • Tonsillar – the brainstem is pushed through the foramen magnum

  13. MEASURING ICP • Supratentorial – Epidural, subdural, intraventricular, intraparenchymal • Involve insertion of a catheter with zeroing at level of ext. auditory meatus • Ventricular is gold standard – also allows drainage of CSF to reduce ICP • ALSO infratentorial and lumbar techniques • Indications for ICP monitoring – • GCS<9 and abnormal CT • GCS<9 and normal CT but >40, low BP or motor posturing

  14. TREATMENT OF RAISED ICP • ABC • Maintenance of cerebral perfusion may require invasive haemodynamic monitoring +/- ICP monitoring • Adequate oxygenation • Ventilation to hypocarbia or normocarbia ( aggressive hyperventilation can cause vasoconstriction) • Maintenances of MAP to maintain CPP • Head elevation • Prevention of venous obstruction – keep head neutral • Adequate sedation or paralysis to prevent coughing

  15. SPECIFIC MEASURES • Surgical intervention • Mannitol – reduces CSF formation, lowers blood viscosity and reduces brain vol. • Frusemide to give rapid diuresis • Steroids to reduce vasogenic oedema around masses • Other cerebroprotective agents – thiopentone • Mild to moderate hypothermia to reduce metabolic rate • Tight glycaemic control • Seizure control

More Related